AM
Insider
Anand Mehra
DirectorAnand Mehra (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in ACRS. Across 1 priced purchase filing, the average 21-session return was -17.0% from execution and -37.6% from disclosure (delay-adjusted; derived). The largest single filing was $1.5M of ACRS (666,666 sh × $2.25, as filed), executed Nov 19 2024.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-17.0%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-37.6%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.5M
shares × price, as filed
Last traded
Nov 19 2024
Filed Nov 20 2024
Volume by month
Buys $1.5M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Not on file
1 filing
Sector per market data · by filing · past 24 months
Most traded names
ACRS
ACRS
ACRS · 1 buy · 0 sells
1 filing
Recent filings
ACRSPURCHASE
Aclaris Therapeutics, Inc.
View filing →
$1.5M666,666 sh × $2.25
Exec Nov 19 2024
Filed Nov 20 2024 · 5:30 PM ET